Third universal definition of myocardial infarction.

ACCF : American College of Cardiology Foundation ACS : acute coronary syndrome AHA : American Heart Association CAD : coronary artery disease CABG : coronary artery bypass grafting CKMB : creatine kinase MB isoform cTn : cardiac troponin CT : computed tomography CV : coefficient of variation ECG : electrocardiogram ESC : European Society of Cardiology FDG : fluorodeoxyglucose h : hour(s) HF : heart failure LBBB : left bundle branch block LV : left ventricle LVH : left ventricular hypertrophy MI : myocardial infarction mIBG : meta-iodo-benzylguanidine min : minute(s) MONICA : Multinational MONItoring of trends and determinants in CArdiovascular disease) MPS : myocardial perfusion scintigraphy MRI : magnetic resonance imaging mV : millivolt(s) ng/L : nanogram(s) per litre Non-Q MI : non-Q wave myocardial infarction NSTEMI : non-ST-elevation myocardial infarction PCI : percutaneous coronary intervention PET : positron emission tomography pg/mL : pictogram(s) per millilitre Q wave MI : Q wave myocardial infarction RBBB : right bundle branch block sec : second(s) SPECT : single photon emission computed tomography STEMI : ST elevation myocardial infarction ST–T : ST-segment –T wave URL : upper reference limit WHF : World Heart Federation WHO : World Health Organization Myocardial infarction (MI) can be recognised by clinical features, including electrocardiographic (ECG) findings, elevated values of biochemical markers (biomarkers) of myocardial necrosis, and by imaging, or may be defined by pathology. It is a major cause of death and disability worldwide. MI may be the first manifestation of coronary artery disease (CAD) or it may occur, repeatedly, in patients with established disease. Information on MI rates can provide useful information regarding the burden of CAD within and across populations, especially if standardized data are collected in a manner that …

Jeroen J. Bax | D. Atar | P. Kolh | E. Antman | H. Bøtker | G. Filippatos | D. Arnar | W. Rosamond | M. Gheorghiade | A. Torbicki | B. Chaitman | M. Simoons | S. Windecker | J. Knuuti | R. Luepker | B. Lindahl | M. Tendera | K. Thygesen | S. Fortmann | D. Moliterno | W. Wijns | P. Vranckx | J. Ravkilde | J. Bassand | S. Mendis | C. Funck-Brentano | K. Taubert | D. Wood | E. Vasilieva | P. Sirnes | C. Deaton | D. Hasdai | A. Vahanian | J. Januzzi | F. Barili | Daniel R Wagner | T. McDonagh | P. Kirchhof | A. Hoes | Carlos Aguiar | James de Lemos | F. Apple | Dan Levy | Franz R. Eberli | U. Sechtem | V. Dean | Željko Reiner | A. Parkhomenko | Ann Bolger | Jose L. Lopez-Sendon | David A. Morrow | R. Fagard | L. K. Newby | Joseph S. Alpert | E. Ohman | Robert F. Storey | Christian Mueller | Harvey D. White | Helmut Baumgartner | João Morais | Bogdan A. Popescu | Steven P. Schulman | Allan S. Jaffe | Hugo A. Katus | Peter M. Clemmensen | Per Johanson | Hanoch Hod | Richard Underwood | Robert O. Bonow | Fausto Pinto | Keith A. A. Fox | Marcello Galvani | Christian W. Hamm | Phillippe Menasché | L. Wallentin | Markku S Nieminen | Sidney C. Smith | Dayi Hu | Douglas Weaver | Stefan James | Biykem Bozkurt | R. Gibbons | M. Hlatky | P. W. Armstrong | Barry F. Uretsky | Ph. Gabriel Steg | Rose Marie Robertson | Alfred A. Bove | Claudio Ceconi | Cyril Moulin | Carlos Aguiar | Wael Almahmeed | Fabio Barili | Kenneth D. Bloch | Raffaele Bugiardini | C. Cannon | Edgardo Escobar | Karl B. Kern | Aleksandar N. Neskovic | Burkert Mathias Pieske | Robert F Storey | Ann F. Bolger | H. White | H. Katus | Keith A Fox | Markku S. Nieminen | José L López-Sendón | Rose Marie Robertson | F. Eberli | M. Galvani | J. Morais | Aleksandar N Neskovic | B. Popescu

[1]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[2]  G. Filippatos,et al.  Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. , 2012, European heart journal.

[3]  J. Alpert,et al.  How to use high-sensitivity cardiac troponins in acute cardiac care , 2012 .

[4]  A. Jaffe,et al.  Why all the struggle about CK-MB and PCI? , 2012, European heart journal.

[5]  G. Lamas,et al.  Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort. , 2012, American heart journal.

[6]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[7]  H. White.  The Prequel: Defining Prognostically Important Criteria in the Periprocedural PCI Troponin Saga , 2012, Circulation. Cardiovascular interventions.

[8]  A. Folsom,et al.  Twenty-Two–Year Trends in Incidence of Myocardial Infarction, Coronary Heart Disease Mortality, and Case Fatality in 4 US Communities, 1987–2008 , 2012, Circulation.

[9]  G. Hillis,et al.  Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery , 2012 .

[10]  S. Pocock,et al.  Long-Term Cardiovascular Mortality After Procedure-Related or Spontaneous Myocardial Infarction in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: A Collaborative Analysis of Individual Patient Data From the FRISC II, ICTUS, and RITA-3 Trials (FIR) , 2012, Circulation.

[11]  D. Wood,et al.  Mechanisms of Myocardial Infarction in Women Without Angiographically Obstructive Coronary Artery Disease , 2011, Circulation.

[12]  S. Yusuf,et al.  High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. , 2011, Clinical chemistry.

[13]  D. Xavier,et al.  High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study. , 2011, Clinical biochemistry.

[14]  H. White.  Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? , 2011, Journal of the American College of Cardiology.

[15]  Denis Xavier,et al.  Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[16]  B. Gersh,et al.  Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction. , 2011, The American journal of cardiology.

[17]  Eric Boerwinkle,et al.  Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.

[18]  N. Weissman,et al.  A suggested roadmap for cardiovascular ultrasound research for the future. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  D. Newby,et al.  Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. , 2011, JAMA.

[20]  V. Hasselblad,et al.  Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. , 2011, JAMA.

[21]  Kari Kuulasmaa,et al.  World Health Organization definition of myocardial infarction: 2008-09 revision. , 2011, International journal of epidemiology.

[22]  Stephan Achenbach,et al.  Cardiac imaging after myocardial infarction. , 2011, European heart journal.

[23]  Pascal Vranckx,et al.  Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.

[24]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[25]  G. Stone,et al.  Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention , 2010, Circulation. Cardiovascular interventions.

[26]  Gary S Mintz,et al.  In-stent restenosis in the drug-eluting stent era. , 2010, Journal of the American College of Cardiology.

[27]  James McCord,et al.  Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. , 2010, Circulation.

[28]  Michael Jerosch-Herold,et al.  Assessment of acute myocardial infarction: current status and recommendations from the North American society for cardiovascular imaging and the European society of cardiac radiology , 2010, The International Journal of Cardiovascular Imaging.

[29]  P. Serruys,et al.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium , 2010, European heart journal.

[30]  P. Armstrong,et al.  Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial. , 2010, American heart journal.

[31]  S. de Servi,et al.  Prognostic Value of Isolated Troponin I Elevation After Percutaneous Coronary Intervention , 2010, Circulation. Cardiovascular interventions.

[32]  Christopher M O'Connor,et al.  Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. , 2010, Journal of the American College of Cardiology.

[33]  Mario Plebani,et al.  Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[34]  F. Apple,et al.  Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay. , 2010, Clinical biochemistry.

[35]  A. Lardo,et al.  Assessment of coronary blood flow with computed tomography and magnetic resonance imaging , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[36]  A. Jaffe,et al.  Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. , 2010, Clinical chemistry.

[37]  Albert J. Sinusas,et al.  Multimodality Imaging of Myocardial Injury and Remodeling , 2010, Journal of Nuclear Medicine.

[38]  H. Taegtmeyer.  Tracing Cardiac Metabolism In Vivo: One Substrate at a Time , 2010, Journal of Nuclear Medicine.

[39]  A. Jaffe,et al.  Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.

[40]  A. Beek,et al.  Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction , 2010, Heart.

[41]  R. Kim,et al.  Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. , 2009, Journal of the American College of Cardiology.

[42]  M. Pfeffer,et al.  A sensitive cardiac troponin T assay in stable coronary artery disease. , 2009, The New England journal of medicine.

[43]  Regina M. Hardison,et al.  The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction , 2009, Circulation.

[44]  D. Jacobs,et al.  The effect of changing diagnostic algorithms on acute myocardial infarction rates. , 2009, Annals of epidemiology.

[45]  Karen A. Hartman,et al.  Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. , 2009, Journal of the American College of Cardiology.

[46]  F. Epstein,et al.  Multimodality cardiovascular molecular imaging, part I. , 2008, Circulation. Cardiovascular imaging.

[47]  J. Alpert,et al.  Diagnostic application of the universal definition of myocardial infarction in the intensive care unit , 2008, Current opinion in critical care.

[48]  A. Jaffe,et al.  Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary Intervention: An Analysis of Preintervention and Postintervention Troponin T Levels in 5487 Patients , 2008, Circulation. Cardiovascular interventions.

[49]  A. Jaffe,et al.  Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary InterventionCLINICAL PERSPECTIVE , 2008 .

[50]  Bekele Afessa,et al.  Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients , 2008, Critical care medicine.

[51]  Fred S Apple,et al.  Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.

[52]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[53]  Robert H Christenson,et al.  National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. , 2007, Circulation.

[54]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[55]  D. Pennell,et al.  The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. , 2007, European heart journal.

[56]  Fred S Apple,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. , 2007, Circulation.

[57]  A. Jaffe,et al.  National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. , 2007, Clinical chemistry.

[58]  D. Morrow,et al.  Benchmarks for the Assessment of Novel Cardiovascular Biomarkers , 2007, Circulation.

[59]  A. Jaffe.  Chasing troponin: how low can you go if you can see the rise? , 2006, Journal of the American College of Cardiology.

[60]  G. Hillis,et al.  Relationship Between Postoperative Cardiac Troponin I Levels and Outcome of Cardiac Surgery , 2006, Circulation.

[61]  R. Bugiardini,et al.  Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. , 2006, Archives of internal medicine.

[62]  Fred S Apple,et al.  Biomarkers in acute cardiac disease: the present and the future. , 2006, Journal of the American College of Cardiology.

[63]  A. Jaffe,et al.  Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. , 2006, Clinical chemistry.

[64]  M. Burritt,et al.  Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. , 2006, European heart journal.

[65]  J. Herrmann.  Peri-procedural myocardial injury: 2005 update. , 2005, European heart journal.

[66]  C. Sprung,et al.  Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients* , 2005, Critical care medicine.

[67]  S. Petersen,et al.  Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury: Insights From Cardiovascular Magnetic Resonance Imaging , 2005, Circulation.

[68]  S. Hill,et al.  Determination of Troponin I Release After CABG Surgery , 2005, Journal of cardiac surgery.

[69]  S. Petersen,et al.  Relationship of irreversible myocardial injury to troponin I and creatine kinase-MB elevation after coronary artery bypass surgery: insights from cardiovascular magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[70]  A. Jaffe,et al.  The quantification of infarct size. , 2004, Journal of the American College of Cardiology.

[71]  M. Mosseri,et al.  Cardiac troponin after major vascular surgery: the role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization. , 2004, Journal of the American College of Cardiology.

[72]  C. Pizzi,et al.  Endothelial Function Predicts Future Development of Coronary Artery Disease: A Study of Women With Chest Pain and Normal Coronary Angiograms , 2004, Circulation.

[73]  Matthew D. Robson,et al.  Effects of Off-Pump Versus On-Pump Coronary Surgery on Reversible and Irreversible Myocardial Injury: A Randomized Trial Using Cardiovascular Magnetic Resonance Imaging and Biochemical Markers , 2004, Circulation.

[74]  C. Gustavsson,et al.  Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury , 2004, Scandinavian cardiovascular journal : SCJ.

[75]  R. Asinger,et al.  ST-segment elevation in conditions other than acute myocardial infarction. , 2003, The New England journal of medicine.

[76]  P. Doyle,et al.  Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. , 2003, Clinical chemistry.

[77]  Mark E Josephson,et al.  Use of the electrocardiogram in acute myocardial infarction. , 2003, The New England journal of medicine.

[78]  E. Topol,et al.  Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. , 2002, Journal of the American College of Cardiology.

[79]  S. Kathiresan,et al.  A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. , 2002, Journal of the American College of Cardiology.

[80]  F Unger,et al.  Incidence, Predictors, and Significance of Abnormal Cardiac Enzyme Rise in Patients Treated With Bypass Surgery in the Arterial Revascularization Therapies Study (ARTS) , 2001, Circulation.

[81]  B. Gersh,et al.  Unrecognized Myocardial Infarction , 2001, Annals of Internal Medicine.

[82]  N. Moatti,et al.  Cardiac troponin I: Its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery , 2001, Critical care medicine.

[83]  B. Chaitman,et al.  Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. , 2001, Journal of the American College of Cardiology.

[84]  P. Macfarlane.  Age, sex, and the ST amplitude in health and disease. , 2001, Journal of electrocardiology.

[85]  T. Nageh,et al.  Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures , 2000, Annals of clinical biochemistry.

[86]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[87]  Deepak L. Bhatt,et al.  Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. , 2000, Circulation.

[88]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[89]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[90]  D Freimark,et al.  Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction. , 1999, Journal of the American College of Cardiology.

[91]  W R Dassen,et al.  Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary artery in acute anterior myocardial infarction. , 1999, Journal of the American College of Cardiology.

[92]  Mylan C. Cohen,et al.  Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. , 1999, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[93]  M. Josephson,et al.  Usefulness of ST-segment elevation in lead III exceeding that of lead II for identifying the location of the totally occluded coronary artery in inferior wall myocardial infarction. , 1998, The American journal of cardiology.

[94]  R. Califf,et al.  Myonecrosis after revascularization procedures. , 1998, Journal of the American College of Cardiology.

[95]  G S Wagner,et al.  Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. , 1996, The New England journal of medicine.

[96]  A. Jaffe,et al.  Myocardial injury in critically ill patients : a frequently unrecognized complication , 1995 .

[97]  L. Fleisher,et al.  Postoperative myocardial ischemia: etiology of cardiac morbidity or manifestation of underlying disease? , 1995, Journal of clinical anesthesia.

[98]  J. López-Sendón,et al.  Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2, and V3. , 1985, Journal of the American College of Cardiology.

[99]  M. Bertrand,et al.  Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. , 1982, Circulation.

[100]  R. Ideker,et al.  Correlation of Postmortem Anatomic Findings with Electrocardiographic Changes in Patients with Myocardial Infarction: Retrospective Study of Patients with Typical Anterior and Posterior Infarcts , 1977, Circulation.

[101]  R. Jennings,et al.  Structural Changes in Myocardium During Acute Ischemia , 1974, Circulation research.

[102]  L. Horan,et al.  Significance of the Diagnostic Q Wave of Myocardial Infarction , 1971, Circulation.

[103]  Fred S Apple,et al.  Analytical characteristics of high-sensitivity cardiac troponin assays. , 2012, Clinical chemistry.

[104]  H. White.  Pathobiology of Troponin Elevations , 2011 .

[105]  M. Laakso,et al.  Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. , 2010, European heart journal.

[106]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[107]  M. Cowie,et al.  Cardiac sympathetic imaging with mIBG in heart failure. , 2010, JACC. Cardiovascular imaging.

[108]  J. Alpert,et al.  Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .

[109]  J. Guermonprez,et al.  Troponin T levels in detection of perioperative myocardial infarction after coronary artery bypass surgery. , 2004, Clinical laboratory.

[110]  M. Burritt,et al.  Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. , 2004, Chest.

[111]  L. Holmvang,et al.  Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery. , 2002, Chest.

[112]  P Maison-Blanche,et al.  Autonomic influences on ventricular repolarization in congestive heart failure. , 2001, Journal of electrocardiology.

[113]  D. Freimark,et al.  Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads: V7–9 , 1998 .

[114]  V. Paul,et al.  Recruited collateral channels are not responsible for ischemic preconditioning during single vessel angioplasty , 1998 .